Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' NEVE KA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 30 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Nelson, CS; Ikeda, M; Gompf, HS; Robinson, ML; Fuchs, NK; Yoshioka, T; Neve, KA; Allen, CN
      Regulation of melatonin 1a receptor signaling and trafficking by asparagine-124

      MOLECULAR ENDOCRINOLOGY
    2. Watts, VJ; Taussig, R; Neve, RL; Neve, KA
      Dopamine D-2 receptor-induced heterologous sensitization of adenylyl cyclase requires G alpha(s): Characterization G alpha(s)-insensitive mutants of adenylyl cyclase V

      MOLECULAR PHARMACOLOGY
    3. Neve, KA; Cumbay, MG; Thompson, KR; Yang, R; Buck, DC; Watts, VJ; Durand, CJ; Teeter, MM
      Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D-2 receptor

      MOLECULAR PHARMACOLOGY
    4. Schutzer, WE; Watts, VJ; Chapman, J; Cumbay, MG; Neve, KA; Neve, RL; Mader, SL
      Viral-mediated gene delivery of constitutively activated G alpha s alters vasoreactivity

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    5. Neve, KA
      Religion and the American constitutional experiment: Essential rights and liberties

      THEOLOGY TODAY
    6. Wilcox, RE; Huang, WH; Brusniak, MYK; Wilcox, DM; Pearlman, RS; Teeter, MM; DuRand, CJ; Wiens, BL; Neve, KA
      CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors

      JOURNAL OF MEDICINAL CHEMISTRY
    7. Eshleman, AJ; Carmolli, M; Cumbay, M; Martens, CR; Neve, KA; Janowsky, A
      Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    8. Watts, VJ; Vu, MN; Wiens, BL; Jovanovic, V; Van Tol, HHM; Neve, KA
      Short and long-term heterologous sensitization of adenylate cyclase by D-4dopamine receptors

      PSYCHOPHARMACOLOGY
    9. WATTS VJ; JOVANOVIC V; VANTOL HHM; NEVE KA
      INTERACTIONS BETWEEN D4 DOPAMINE-RECEPTORS AND ADENYLATE-CYCLASE - HETEROLOGOUS SENSITIZATION OF CAMP ACCUMULATION

      The FASEB journal
    10. JOHNSON RA; ESHLEMAN AJ; MEYERS T; NEVE KA; JANOWSKY A
      [H-3]SUBSTRATE-SPECIFIC AND CELL-SPECIFIC EFFECTS OF UPTAKE INHIBITORS ON HUMAN DOPAMINE AND SEROTONIN TRANSPORTER-MEDIATED EFFLUX

      Synapse
    11. WATTS VJ; WIENS BL; CUMBAY MG; VU MN; NEVE RL; NEVE KA
      SELECTIVE ACTIVATION OF G-ALPHA(O) BY D-2L DOPAMINE-RECEPTORS IN NS20Y NEUROBLASTOMA

      The Journal of neuroscience
    12. SONG S; WANG YM; BAK SY; DURING MJ; BRYAN J; ASHE O; ULLREY DB; TRASK LE; GRANT FD; OMALLEY KL; RIEDEL H; GOLDSTEIN DS; NEVE KA; LAHOSTE GJ; MARSHALL JF; HAYCOCK JW; NEVE RL; GELLER AI
      MODULATION OF RAT ROTATIONAL BEHAVIOR BY DIRECT GENE-TRANSFER OF CONSTITUTIVELY ACTIVE PROTEIN-KINASE-C INTO NIGROSTRIATAL NEURONS

      The Journal of neuroscience
    13. WIENS BL; NELSON CS; NEVE KA
      CONTRIBUTION OF SERINE RESIDUES TO CONSTITUTIVE AND AGONIST-INDUCED SIGNALING VIA THE D-2S DOPAMINE-RECEPTOR - EVIDENCE FOR MULTIPLE, AGONIST-SPECIFIC ACTIVE CONFORMATIONS

      Molecular pharmacology
    14. LUO YQ; KOKKONEN GC; WANG XT; NEVE KA; ROTH GS
      D2 DOPAMINE-RECEPTORS STIMULATE MITOGENESIS THROUGH PERTUSSIS-TOXIN-SENSITIVE G-PROTEINS AND RAS-INVOLVED ERK AND SAP JNK PATHWAYS IN RAT C6-D2L GLIOMA-CELLS/

      Journal of neurochemistry
    15. WILCOX RE; TSENG T; BRUSNIAK MYK; GINSBURG B; PEARLMAN RS; TEETER M; DURAND C; STARR S; NEVE KA
      COMFA-BASED PREDICTION OF AGONIST AFFINITIES AT RECOMBINANT D1 VS D2 DOPAMINE-RECEPTORS

      Journal of medicinal chemistry
    16. NEVE KA
      ATYPICAL NEUROLEPTICS HAVE LOW-AFFINITY FOR DOPAMINE D-2 RECEPTORS ORARE SELECTIVE FOR D-4 RECEPTORS - COMMENTARY

      Neuropsychopharmacology
    17. KOZELL LB; NEVE KA
      CONSTITUTIVE ACTIVITY OF A CHIMERIC D-2 D-1 DOPAMINE-RECEPTOR/

      Molecular pharmacology
    18. WATTS VJ; NEVE KA
      ACTIVATION OF TYPE-II ADENYLATE-CYCLASE BY D-2 AND D-4 BUT NOT D-3 DOPAMINE-RECEPTORS

      Molecular pharmacology
    19. ESHLEMAN AJ; STEWART E; EVENSON AK; MASON JN; BLAKELY RD; JANOWSKY A; NEVE KA
      METABOLISM OF CATECHOLAMINES BY CATECHOL-O-METHYLTRANSFERASE IN CELLSEXPRESSING RECOMBINANT CATECHOLAMINE TRANSPORTERS

      Journal of neurochemistry
    20. NEVE KA; WATTS VJ
      HETEROLOGOUS SENSITIZATION OF ADENYLATE-CYCLASE BY G(I)-COUPLED RECEPTORS

      The FASEB journal
    21. WATTS VJ; NEVE KA
      SENSITIZATION OF ENDOGENOUS AND RECOMBINANT ADENYLATE-CYCLASE BY ACTIVATION OF D-2 DOPAMINE-RECEPTORS

      Molecular pharmacology
    22. BRUSNIAK MYK; PEARLMAN RS; NEVE KA; WILCOX RE
      COMPARATIVE MOLECULAR-FIELD ANALYSIS-BASED PREDICTION OF DRUG AFFINITIES AT RECOMBINANT D1A DOPAMINE-RECEPTORS

      Journal of medicinal chemistry
    23. COX BA; ROSSER MP; KOZLOWSKI MR; DUWE KM; NEVE RL; NEVE KA
      REGULATION AND FUNCTIONAL-CHARACTERIZATION OF A RAT RECOMBINANT DOPAMINE D3 RECEPTOR

      Synapse
    24. NEVE KA; WIENS BL
      4 WAYS OF BEING AN AGONIST - MULTIPLE SEQUENCE DETERMINANTS OF EFFICACY AT D2-DOPAMINE RECEPTORS

      Biochemical Society transactions
    25. ESHLEMAN AJ; NEVE RL; JANOWSKY A; NEVE KA
      CHARACTERIZATION OF A RECOMBINANT HUMAN DOPAMINE TRANSPORTER IN MULTIPLE CELL-LINES

      The Journal of pharmacology and experimental therapeutics
    26. STARR S; KOZELL LB; NEVE KA
      DRUG-INDUCED UP-REGULATION OF DOPAMINE D2 RECEPTORS ON CULTURED-CELLS

      Journal of neurochemistry
    27. WATTS VJ; LAWLER CP; FOX DR; NEVE KA; NICHOLS DE; MAILMAN RB
      LSD AND STRUCTURAL ANALOGS - PHARMACOLOGICAL EVALUATION AT D-1 DOPAMINE-RECEPTORS

      Psychopharmacology
    28. ESHLEMAN AJ; HENNINGSEN RA; NEVE KA; JANOWSKY A
      RELEASE OF DOPAMINE VIA THE HUMAN TRANSPORTER

      Molecular pharmacology
    29. KOZELL LB; MACHIDA CA; NEVE RL; NEVE KA
      CHIMERIC D1 D2 DOPAMINE-RECEPTORS - DISTINCT DETERMINANTS OF SELECTIVE EFFICACY, POTENCY, AND SIGNAL-TRANSDUCTION/

      The Journal of biological chemistry
    30. WATTS VJ; LAWLER CP; KNOERZER T; MAYLEBEN MA; NEVE KA; NICHOLS DE; MAILMAN RB
      HEXAHYDROBENZO[A]PHENANTHRIDINES - NOVEL DOPAMINE-D(3) RECEPTOR LIGANDS

      European journal of pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 04:08:19